Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.85 |
| ▸ | CA9 | Q16790 | 4/20 | 0.81 |
| ▸ | PTGES | O14684 | 2/20 | 0.71 |
| ▸ | CA1 | P00915 | 1/20 | 0.68 |
| ▸ | CA2 | P00918 | 1/20 | 0.68 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.63 |
| ▸ | NT5E | P21589 | 2/20 | 0.61 |
| ▸ | CETP | P11597 | 1/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.61 |
| ▸ | TOP2A | P11388 | 1/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.61 |
| ▸ | RELA | Q04206 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Betulin Diacetate SCHEMBL21800881 | 1.00 | SLC10A1 (0.85) | SLC10A1CA9PTGESCA1CA2 | |
| Betulin Diacetate SCHEMBL10152757 | 1.00 | SLC10A1 (0.85) | SLC10A1CA9PTGESCA1CA2 | |
| Betulin Diacetate SCHEMBL2734061 | 1.00 | SLC10A1 (0.85) | SLC10A1CA9PTGESCA1CA2 | |
| Betulin Diacetate SCHEMBL6112851 | 1.00 | SLC10A1 (0.85) | SLC10A1CA9PTGESCA1CA2 | |
| Betulin Diacetate SCHEMBL14339168 | 1.00 | SLC10A1 (0.85) | SLC10A1CA9PTGESCA1CA2 | |
| Betulin Diacetate SCHEMBL10523254 | 1.00 | SLC10A1 (0.85) | SLC10A1CA9PTGESCA1CA2 | |
| Betulin Diacetate SCHEMBL14134382 | 1.00 | SLC10A1 (0.85) | SLC10A1CA9PTGESCA1CA2 | |
| Betulin Diacetate SCHEMBL10001907 | 1.00 | SLC10A1 (0.85) | SLC10A1CA9PTGESCA1CA2 | |
| SCHEMBL14344558 | 0.95 | SLC10A1 (0.78) | SLC10A1CA9PTGESCA1CA2 | |
| SCHEMBL14368363 | 0.95 | SLC10A1 (0.78) | SLC10A1CA9PTGESCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088757-B2 | Betulinol derivatives as anti-cancer agents | BIORINGS LLC (US) | 2012-01-03 | — | — | US | disclosed |
| US-20090176753-A1 | Betulinol derivatives as anti-cancer agents | SAXENA RESEARCH, LLC | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176753-A1 | Betulinol derivatives as anti-cancer agents | BET1, BRDT, BRCA1 | SLC10A1 2305/4885CA9 270/4885PTGES 2093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.